NICE (UK National Institute for Clinical Excellence) reaches milestone with EFM (electronic foetal monitoring) draft recommendations
This article was originally published in Clinica
The UK's National Institute for Clinical Excellence (NICE) has made public a draft of its recommendations on the use of intrapartum electronic foetal monitoring (EFM). The document is the first final draft of a device appraisal to be made public by NICE, reflecting last month's board decision to publish provisional technology assessment findings.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.